Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 74
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int J Mol Sci ; 23(6)2022 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-35328784

RESUMEN

Fine temperature control is essential in homeothermic animals. Both hyper- and hypothermia can have deleterious effects. Multiple, efficient and partly redundant mechanisms of adjusting the body temperature to the value set by the internal thermostat exist. The neural circuitry of temperature control and the neurotransmitters involved are reviewed. The GABAergic inhibitory output from the brain thermostat in the preoptic area POA to subaltern neural circuitry of temperature control (Nucleus Raphe Dorsalis and Nucleus Raphe Pallidus) is a function of the balance between the (opposite) effects mediated by the transient receptor potential receptor TRPM2 and EP3 prostaglandin receptors. Activation of TRPM2-expressing neurons in POA favors hypothermia, while inhibition has the opposite effect. Conversely, EP3 receptors induce elevation in body temperature. Activation of EP3-expressing neurons in POA results in hyperthermia, while inhibition has the opposite effect. Agonists at TRPM2 and/or antagonists at EP3 could be beneficial in hyperthermia control. Activity of the neural circuitry of temperature control is modulated by a variety of 5-HT receptors. Based on the theoretical model presented the "ideal" antidote against serotonin syndrome hyperthermia appears to be an antagonist at the 5-HT receptor subtypes 2, 4 and 6 and an agonist at the receptor subtypes 1, 3 and 7. Very broadly speaking, such a profile translates in a sympatholytic effect. While a compound with such an ideal profile is presently not available, better matches than the conventional antidote cyproheptadine (used off-label in severe serotonin syndrome cases) appear to be possible and need to be identified.


Asunto(s)
Hipertermia Inducida , Hipotermia , Síndrome de la Serotonina , Canales Catiónicos TRPM , Animales , Antídotos , Ciproheptadina/farmacología , Hipertermia , Serotonina/farmacología
2.
Biomed Pharmacother ; 149: 112892, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35358796

RESUMEN

PURPOSE: Obesity and overweight are metabolic disorders associated with oxidative stress, and risk factors for many chronic diseases. We sought to investigate the effects of Metaswitch dietary supplement on weight gain and associated acute metabolic alterations in a high-fat diet-induced overweight rat model. METHODS: Female Sprague Dawley (SD) rats were put into 6 groups. Control groups were fed normal (NCD) or high-fat diet (HFD). Treatment groups on HFD receieved 3 different daily doses of Metaswitch for 3 weeks. Another group on HFD received Slimrite® (phenylpropanolamine), a standard drug. Rats on HFD also received cyproheptadine to stimulate appetite. Food consumption and anthropometric parameters were determined weekly. Serum lipids, glucose level, hepatic lipid peroxidation, and antioxidant activity were used to assess overweight in rats. RESULTS: Food intake remained relatively constant among groups. Rats on HFD had significantly increased body weight compared to rats fed NCD. Metaswitch significantly prevented weight gain; this effect was greater or similar to rats administered Slimrite, but was not dose-dependant. No significant changes occurred in the levels of serum lipids and glucose among the groups. However, serum triglyceride (TG) was significantly increased. The TG/HDL-C ratio revealed significant metabolic alterations which was prevented by Metaswitch. Catalase activity was significantly decreased in the HFD untreated group but was restored in Metaswitch-treated groups. CONCLUSIONS: A 3-week HFD regimen with cyproheptadine supplementation in female SD rats resulted in a significant increase in body weight and acute metabolic alterations. The aforementioned changes were found to have been prevented with the administration of Metaswitch.


Asunto(s)
Dieta Alta en Grasa , Enfermedades no Transmisibles , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Peso Corporal , Ciproheptadina/farmacología , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Femenino , Glucosa/farmacología , Sobrepeso/tratamiento farmacológico , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley , Aumento de Peso
3.
Sci Rep ; 8(1): 7377, 2018 05 09.
Artículo en Inglés | MEDLINE | ID: mdl-29743517

RESUMEN

The receptor tyrosine kinase, erythropoietin-producing hepatocellular A4 (EphA4), was recently identified as a molecular target for Alzheimer's disease (AD). We found that blockade of the interaction of the receptor and its ligands, ephrins, alleviates the disease phenotype in an AD transgenic mouse model, suggesting that targeting EphA4 is a potential approach for developing AD interventions. In this study, we identified five FDA-approved drugs-ergoloid, cyproheptadine, nilotinib, abiraterone, and retapamulin-as potential inhibitors of EphA4 by using an integrated approach combining virtual screening with biochemical and cellular assays. We initially screened a database of FDA-approved drugs using molecular docking against the ligand-binding domain of EphA4. Then, we selected 22 candidate drugs and examined their inhibitory activity towards EphA4. Among them, five drugs inhibited EphA4 clustering induced by ephrin-A in cultured primary neurons. Specifically, nilotinib, a kinase inhibitor, inhibited the binding of EphA4 and ephrin-A at micromolar scale in a dosage-dependent manner. Furthermore, nilotinib inhibited the activation of EphA4 and EphA4-dependent growth cone collapse in cultured hippocampal neurons, demonstrating that the drug exhibits EphA4 inhibitory activity in cellular context. As demonstrated in our combined computational and experimental approaches, repurposing of FDA-approved drugs to inhibit EphA4 may provide an alternative fast-track approach for identifying and developing new treatments for AD.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Simulación del Acoplamiento Molecular , Pirimidinas/farmacología , Receptor EphA4/antagonistas & inhibidores , Enfermedad de Alzheimer/metabolismo , Androstenos/metabolismo , Androstenos/farmacología , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/metabolismo , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Ciproheptadina/metabolismo , Ciproheptadina/farmacología , Modelos Animales de Enfermedad , Diterpenos/metabolismo , Diterpenos/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Ligandos , Ratones , Ratones Transgénicos , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Unión Proteica , Dominios Proteicos , Pirimidinas/metabolismo , Receptor EphA4/metabolismo
4.
Biochem Pharmacol ; 107: 14-28, 2016 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-26896646

RESUMEN

New antiretroviral agents with alternative mechanisms are needed to complement the combination therapies used to treat HIV-1 infections. Here we report the identification of bioavailable molecules that interfere with the gene expression processes of HIV-1. The compounds were detected by screening a small library of FDA-approved drugs with an assay based on measuring the displacement of Rev, and essential virus-encoded protein, from its high-affinity RNA binding site. The antiretroviral activity of two hits was based on interference with post-integration steps of the HIV-1 cycle. Both hits inhibited RRE-Rev complex formation in vitro, and blocked LTR-dependent gene expression and viral transcription in cellular assays. The best compound altered the splicing pattern of HIV-1 transcripts in a manner consistent with Rev inhibition. This mechanism of action is different from those used by current antiretroviral agents. The screening hits recognized the Rev binding site in the viral RNA, and the best compound did so with substantial selectivity, allowing the identification of a new RNA-binding scaffold. These results may be used for developing novel antiretroviral drugs.


Asunto(s)
Fármacos Anti-VIH/farmacología , Regulación Viral de la Expresión Génica/efectos de los fármacos , VIH-1/efectos de los fármacos , ARN Viral/metabolismo , Elementos de Respuesta/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Productos del Gen rev del Virus de la Inmunodeficiencia Humana/antagonistas & inhibidores , Fármacos Anti-VIH/efectos adversos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Clomifeno/efectos adversos , Clomifeno/farmacología , Ciproheptadina/efectos adversos , Ciproheptadina/farmacología , Evaluación Preclínica de Medicamentos , Genes Reporteros/efectos de los fármacos , VIH-1/crecimiento & desarrollo , VIH-1/metabolismo , Ensayos Analíticos de Alto Rendimiento , Humanos , Fragmentos de Péptidos/antagonistas & inhibidores , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Dominios y Motivos de Interacción de Proteínas , Empalme del ARN/efectos de los fármacos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Bibliotecas de Moléculas Pequeñas , Productos del Gen rev del Virus de la Inmunodeficiencia Humana/química , Productos del Gen rev del Virus de la Inmunodeficiencia Humana/genética , Productos del Gen rev del Virus de la Inmunodeficiencia Humana/metabolismo
5.
Drug Res (Stuttg) ; 65(4): 205-13, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24886981

RESUMEN

BACKGROUND: Capparis thonningii Schum. (Capparaceae) is used in traditional African Medicine for the treatment of mood disorders. OBJECTIVE: The study investigates antidepressant and anxiolytic activities of methanol root extract of C. thonningii (CT). METHODS: CT (25-100 mg/kg, p. o.) was administered 1 h before behavioral studies were carried out in mice. Antidepressant effect was investigated using the forced swimming test (FST) and tail suspension test (TST). The anxiolytic effect was evaluated using the elevated-plus maze test (EPM), hole-board test (HBT), and light-dark test. RESULTS: CT (25 and 50 mg/kg) increased swimming activity (P<0.05) by 92.73% and attenuated immobility time by 35.72%, similar to anti-immobility effect of imipramine (33.87%) in FST. In addition, CT (50 mg/kg) significantly (P<0.01) reduced immobility time by 30.24% in TST. -However, the antidepressant-like effect elicited by CT was reversed by metergoline, cyproheptadine, and sulpiride (40.81, 45.93, and 48.52%, respectively) pretreatment but prazosin, and yohimbine failed to reverse this antidepressant-like effect. Similar to diazepam, CT (25 mg/kg) increased duration of open arms exploration (P<0.05) by 43.73% in EPM, number of head-dips (HBT) (90.32%), and time spent in the light compartment by 45.77% in light/dark test indicating anxiolytic-like effect. The anxiolytic-like effect of CT was reversed by flumazenil pretreatment. CONCLUSION: The findings from this study suggest antidepressant-like effect of C. thonningii involving interaction with serotonergic (5-HT2), dopaminergic (D2), noradrenergic (α1 and α2), and muscarinic cholinergic systems; and anxiolytic effect through an interaction with GABAA benzodiazepine receptor.


Asunto(s)
Ansiolíticos/farmacología , Antidepresivos/farmacología , Monoaminas Biogénicas/metabolismo , Capparis/química , Neuronas Colinérgicas/efectos de los fármacos , Extractos Vegetales/farmacología , Ácido gamma-Aminobutírico/metabolismo , Antagonistas Adrenérgicos/farmacología , Animales , Atropina/farmacología , Conducta Animal/efectos de los fármacos , Colinérgicos/farmacología , Neuronas Colinérgicas/metabolismo , Ciproheptadina/farmacología , Antagonistas de Dopamina/farmacología , Femenino , Flumazenil/farmacología , GABAérgicos/farmacología , Pérdida de Tono Postural/efectos de los fármacos , Masculino , Metergolina/farmacología , Metanol/química , Ratones , Antagonistas Muscarínicos/farmacología , Extractos Vegetales/antagonistas & inhibidores , Raíces de Plantas/química , Prazosina/farmacología , Antagonistas de la Serotonina/farmacología , Sulpirida/farmacología , Yohimbina/farmacología
6.
Eur J Pharm Sci ; 40(4): 282-8, 2010 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-20381614

RESUMEN

Drug-drug interactions involving hepatic drug transporters may have clinical consequences and jeopardize development of promising drug candidates. Organic anion transporting polypeptides (OATP/Oatp) and the organic cation transporters (OCT/Oct) are among the most important transporters involved in xenobiotic uptake in the liver. In the present study, 179 molecules have been tested as inhibitors of the uptake of estradiol-17betaD-glucuronide (E(2)17betaG), substrate of OATP1B1/3 (rOatp), or 1-methyl-4-phenylpyridinium (MPP+), substrate of OCT1 (rOct1), into suspended cryopreserved hepatocytes from humans and rats. Uptake was assessed in 96-well plates by measuring intracellular accumulation of radioactive substrate in hepatocytes in presence or absence of inhibitor. In rat hepatocytes 140 compounds were identified as inhibitors (inhibition at 20 microM > or = 30%) of E(2)17betaG uptake and 77 compounds inhibitors of MPP+ uptake. The most potent inhibitors of rOatp and rOct1 were dantrolene sodium (K(i)=2 +/- 9 microM) and bepridil (K(i)=14 +/- 2 microM), respectively. In human hepatocytes, the most potent inhibitors of E(2)17betaG and MPP+ uptake were capsazepine (K(i)=14 +/- 5 microM) and cyproheptadine (K(i)=19+/-3 microM), respectively. Structure-activity relationship (SAR) analysis of all tested compounds suggested that lipophilicity, polarity, pK(a) and the number of hydrogen bond donors and acceptors play a role in their interaction with the transporters investigated. The method used here is a simple tool to screen large number of compounds as inhibitors of the uptake of substrates into suspended hepatocytes.


Asunto(s)
1-Metil-4-fenilpiridinio/farmacocinética , Inhibidores Enzimáticos/farmacología , Estradiol/análogos & derivados , Hepatocitos/efectos de los fármacos , Transportadores de Anión Orgánico Sodio-Independiente/antagonistas & inhibidores , Transportadores de Anión Orgánico/antagonistas & inhibidores , Animales , Bepridil/farmacología , Transporte Biológico/efectos de los fármacos , Capsaicina/análogos & derivados , Capsaicina/farmacología , Criopreservación , Ciproheptadina/farmacología , Dantroleno/farmacología , Evaluación Preclínica de Medicamentos , Interacciones Farmacológicas , Estradiol/farmacocinética , Hepatocitos/enzimología , Hepatocitos/metabolismo , Humanos , Isoenzimas/antagonistas & inhibidores , Transportador 1 de Anión Orgánico Específico del Hígado , Ratas , Miembro 1B3 de la Familia de los Transportadores de Solutos de Aniones Orgánicos , Especificidad de la Especie , Relación Estructura-Actividad
7.
Biocell ; 33(1): 19-24, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19499882

RESUMEN

Cytotoxic properties of plant extracts and drugs being developed for cancer treatment are usually evaluated by a variety of in vivo and in vitro tests carried out in animal or plant based models. In the present study we have evaluated the possibility of using the germinating mung beans (Vigna radiata), for rapid and inexpensive screening of drugs exhibiting cytotoxic properties. Mung beans were allowed to germinate either in tap water or in different drug solutions, and parameters like percent germination, increase in radicle length, change in seedling weight and mitotic index of apical root meristems were determined at two time intervals coinciding with the time at which the radicle length in control group was 1.0 to 1.5 cm (time 0, T0) and 48 h later (T48). Methanol extract of Calotropis procera latex as well as drugs like podophyllotoxin, cyclophosphamide, cyproheptadine and aspirin produced a dose-dependent inhibitory effect on seed germination, seed weight gain, radicle growth and mitotic index in the radicle meristems. The inhibitory effect of some of the drugs tested was associated with reduction in water imbibition. Some of the drugs at higher concentrations allowed seed germination to take place but produced radicle decay and seedling weight loss. Our study shows that germinating V radiata beans could be used as a convenient model for the preliminary screening of drugs exhibiting cytotoxic properties.


Asunto(s)
Citotoxinas/farmacología , Fabaceae/efectos de los fármacos , Germinación/efectos de los fármacos , Semillas/efectos de los fármacos , Aspirina/farmacología , Ciclofosfamida/farmacología , Ciproheptadina/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Fabaceae/fisiología , Germinación/fisiología , Extractos Vegetales/farmacología , Podofilotoxina/farmacología , Semillas/fisiología
8.
J Ethnopharmacol ; 123(2): 330-4, 2009 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-19429380

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Ficus religiosa (Moraceae) is reported to have numerous therapeutic utility in folk medicine. Among different biological activities on central nervous system, it has been reported to be used in ethnomedical treatment of epilepsy, which led us to further explore its anticonvulsant activity in various animal models of epilepsy. AIM OF THE STUDY: To investigate anticonvulsant activity of methanolic extract of figs of Ficus religiosa in animal models and to determine its possible anticonvulsant mechanism. MATERIALS AND METHODS: Anticonvulsant activity of figs extract (25, 50 and 100 mg/kg, i.p.) was studied in seizures induced by maximum electroshock (MES), picrotoxin and pentylenetetrazol (PTZ). Cyproheptadine, a nonselective (5HT(1/2)) serotonin antagonist (4 mg/kg, i.p.) was used to study the reversal of protective effect of extract in the above mentioned models. Acute toxicity, neurotoxicity and potentiation of pentobarbitone induced sleep by extract was also studied. RESULTS: Extract showed no toxicity, potentiated pentobarbitone induced sleep and inhibited seizures induced by MES and picrotoxin in a dose dependent manner. Anticonvulsant effect of extract was comparable to clinically used antiepileptic drugs (phenytoin and diazepam). However, PTZ induced seizures were not inhibited. Animals pretreated with cyproheptadine showed inhibition of the anticonvulsant effect of extract. CONCLUSIONS: These findings suggested that the methanolic extract of figs of Ficus religiosa had anticonvulsant activity against MES and picrotoxin induced convulsions, with no neurotoxic effect, in a dose dependent manner. Inhibition of the anticonvulsant effect of extract by cyproheptadine substantiates the involvement of serotonergic pathways for the anticonvulsant activity of extract.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Epilepsia/tratamiento farmacológico , Ficus/química , Extractos Vegetales/administración & dosificación , Animales , Anticonvulsivantes/aislamiento & purificación , Anticonvulsivantes/toxicidad , Ciproheptadina/farmacología , Diazepam/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Epilepsia/fisiopatología , Masculino , Medicina Tradicional , Ratones , Fenitoína/farmacología , Extractos Vegetales/toxicidad , Serotonina/metabolismo , Antagonistas de la Serotonina/farmacología , Pruebas de Toxicidad
9.
Biocell ; 33(1): 19-24, Apr. 2009. graf
Artículo en Inglés | LILACS | ID: lil-595025

RESUMEN

Cytotoxic properties of plant extracts and drugs being developed for cancer treatment are usually evaluated by a variety of in vivo and in vitro tests carried out in animal or plant based models. In the present study we have evaluated the possibility of using the germinating mung beans (Vigna radiata), for rapid and inexpensive screening of drugs exhibiting cytotoxic properties. Mung beans were allowed to germinate either in tap water or in different drug solutions, and parameters like percent germination, increase in radicle length, change in seedling weight and mitotic index of apical root meristems were determined at two time intervals coinciding with the time at which the radicle length in control group was 1.0 to 1.5 cm (time 0, T0) and 48 h later (T48). Methanol extract of Calotropis procera latex as well as drugs like podophyllotoxin, cyclophosphamide, cyproheptadine and aspirin produced a dose-dependent inhibitory effect on seed germination, seed weight gain, radicle growth and mitotic index in the radicle meristems. The inhibitory effect of some of the drugs tested was associated with reduction in water imbibition. Some of the drugs at higher concentrations allowed seed germination to take place but produced radicle decay and seedling weight loss. Our study shows that germinating V radiata beans could be used as a convenient model for the preliminary screening of drugs exhibiting cytotoxic properties.


Asunto(s)
Aspirina/farmacología , Ciclofosfamida/farmacología , Ciproheptadina/farmacología , Citotoxinas/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Extractos Vegetales/farmacología , Fabaceae , Fabaceae/fisiología , Germinación , Germinación/fisiología , Podofilotoxina/farmacología , Semillas , Semillas/fisiología
10.
Biocell ; 33(1): 19-24, Apr. 2009. graf
Artículo en Inglés | BINACIS | ID: bin-127218

RESUMEN

Cytotoxic properties of plant extracts and drugs being developed for cancer treatment are usually evaluated by a variety of in vivo and in vitro tests carried out in animal or plant based models. In the present study we have evaluated the possibility of using the germinating mung beans (Vigna radiata), for rapid and inexpensive screening of drugs exhibiting cytotoxic properties. Mung beans were allowed to germinate either in tap water or in different drug solutions, and parameters like percent germination, increase in radicle length, change in seedling weight and mitotic index of apical root meristems were determined at two time intervals coinciding with the time at which the radicle length in control group was 1.0 to 1.5 cm (time 0, T0) and 48 h later (T48). Methanol extract of Calotropis procera latex as well as drugs like podophyllotoxin, cyclophosphamide, cyproheptadine and aspirin produced a dose-dependent inhibitory effect on seed germination, seed weight gain, radicle growth and mitotic index in the radicle meristems. The inhibitory effect of some of the drugs tested was associated with reduction in water imbibition. Some of the drugs at higher concentrations allowed seed germination to take place but produced radicle decay and seedling weight loss. Our study shows that germinating V radiata beans could be used as a convenient model for the preliminary screening of drugs exhibiting cytotoxic properties.(AU)


Asunto(s)
Ensayos de Selección de Medicamentos Antitumorales , Aspirina/farmacología , Ciclofosfamida/farmacología , Ciproheptadina/farmacología , Citotoxinas/farmacología , Fabaceae , Fabaceae/fisiología , Germinación , Germinación/fisiología , Extractos Vegetales/farmacología , Podofilotoxina/farmacología , Semillas , Semillas/fisiología
11.
Am J Vet Res ; 68(11): 1265-71, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17975984

RESUMEN

OBJECTIVE: To determine whether oral administration of cyproheptadine or cetirizine blocks the action of serotonin and histamine, respectively, and results in diminished eosinophilic airway inflammation in cats with experimentally induced asthma. ANIMALS: 9 cats in which asthma was experimentally induced through exposure to Bermuda grass allergen (BGA) during a 3-month period. PROCEDURES: Cats were randomized to receive monotherapy with each of 3 treatments for 1 week: placebo (flour in a gelatin capsule, PO, q 12 h), cyproheptadine (8 mg, PO, q 12 h), or cetirizine (5 mg, PO, q 12 h). A 1-week washout period was allowed to elapse between treatments. Prior to and following each 1-week treatment period, blood and bronchoalveolar lavage fluid (BALF) samples were collected. The percentage of eosinophils in BALF was evaluated to determine treatment efficacy. Serum and BALF BGA-specific immunoglobulin contents and plasma and BALF histamine concentrations were determined via ELISAs. Plasma and BALF serotonin concentrations were measured by use of a fluorometric method. RESULTS: The mean +/- SD percentage of eosinophils in BALF did not differ significantly among treatment groups (placebo, 40 +/- 22%; cyproheptadine, 27 +/- 16%; and cetirizine, 31 +/- 20%). Among the treatment groups, BGA-specific immunoglobulin content and histamine and serotonin concentrations were not significantly different. CONCLUSIONS AND CLINICAL RELEVANCE: In cats with experimentally induced asthma, cyproheptadine and cetirizine were not effective in decreasing airway eosinophilic inflammation or in altering several other measured immunologic variables. Neither cyproheptadine nor cetirizine can be advocated as monotherapy for cats with allergen-induced asthma.


Asunto(s)
Asma/veterinaria , Enfermedades de los Gatos/tratamiento farmacológico , Cetirizina/farmacología , Ciproheptadina/farmacología , Antagonistas de los Receptores Histamínicos H1 no Sedantes/farmacología , Eosinofilia Pulmonar/veterinaria , Antagonistas de la Serotonina/farmacología , Animales , Asma/tratamiento farmacológico , Asma/inmunología , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/citología , Enfermedades de los Gatos/inmunología , Gatos , Estudios Cruzados , Cynodon/inmunología , Eosinófilos/inmunología , Histamina/sangre , Inmunoglobulina A/sangre , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Masculino , Eosinofilia Pulmonar/tratamiento farmacológico , Eosinofilia Pulmonar/inmunología , Distribución Aleatoria , Serotonina/sangre , Organismos Libres de Patógenos Específicos
12.
Eur J Pharmacol ; 563(1-3): 233-9, 2007 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-17336291

RESUMEN

Female NC/Jic mice were sensitized and challenged repeatedly at 48 h intervals for 10 and 30 days by painting 1% 2,4,6-trinitrochlorobenzene (TNCB) on both ears. Mice challenged with TNCB for 30 days developed an inflammatory dermatitis with high immunoglobulin E (IgE) titer. Histological analysis with acidic Toluidine Blue staining revealed that dermal mast cells markedly differentiated and intensely degranulated, consistent with a dramatic increase in scratching behavior. A significant increase in total scratching events could be observed in mice treated with TNCB for a short period of 10 days. Extending the term of TNCB application to 30 days, the IgE titer and number of mast cells elevated significantly, and thus various drugs were evaluated pharmacologically by using the mice treated with TNCB for 30 days. Terfenadine and cyproheptadine attenuated the chronic scratching behavior. Tacrolimus and dexamethasone were less effective and cromolyn showed no effect. In addition, terfenadine and tacrolimus suppressed the degranulation of mast cells. The present chronic scratching model could be suitable to evaluate drugs effective for suppression of mast cell differentiation and degranulation by irritation, and may represent a promising tool to develop new drugs for inflammatory pruritus associated with, for example, atopic dermatitis.


Asunto(s)
Antipruriginosos/farmacología , Dermatitis Atópica/complicaciones , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos/métodos , Cloruro de Picrilo , Prurito/prevención & control , Animales , Antipruriginosos/uso terapéutico , Degranulación de la Célula/efectos de los fármacos , Enfermedad Crónica , Cromolin Sódico/farmacología , Ciproheptadina/farmacología , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/inmunología , Dermatitis Atópica/fisiopatología , Dexametasona/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Inmunoglobulina E/sangre , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Ratones , Prurito/etiología , Prurito/inmunología , Prurito/fisiopatología , Tacrolimus/farmacología , Terfenadina/farmacología , Factores de Tiempo
13.
Bioorg Med Chem ; 14(15): 5333-9, 2006 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-16616501

RESUMEN

Antiallergic drug cyproheptadine (Cyp) is known to have inhibitory activities for L-type calcium channels in addition to histamine and serotonin receptors. Since we found that Cyp had an inhibitory activity against N-type calcium channel, Cyp was optimized to obtain more selective N-type calcium channel blocker with analgesic action. As a consequence of the optimization, we found 13 with potent N-type calcium channel inhibitory activity which had lower inhibitory activities against L-type calcium channel, histamine (H1), and serotonin (5-HT2A) receptors than those of Cyp. 13 showed an oral analgesic activity in rat formalin-induced pain model.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo N/efectos de los fármacos , Ciproheptadina/análogos & derivados , Ciproheptadina/farmacología , Diseño de Fármacos , Administración Oral , Animales , Conducta Animal/efectos de los fármacos , Bloqueadores de los Canales de Calcio/síntesis química , Bloqueadores de los Canales de Calcio/química , Línea Celular Tumoral , Ciproheptadina/química , Evaluación Preclínica de Medicamentos , Formaldehído/química , Cobayas , Humanos , Técnicas In Vitro , Masculino , Estructura Molecular , Dolor/inducido químicamente , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Receptores Histamínicos/efectos de los fármacos , Receptores de Serotonina/efectos de los fármacos , Estereoisomerismo , Relación Estructura-Actividad , Células Tumorales Cultivadas
14.
Drug Discov Today ; 11(7-8): 348-54, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16580977

RESUMEN

A survey of novel small-molecule therapeutics reveals that the majority of them result from analogue design and that their market value represents two-thirds of all small-molecule sales. In natural science, the term analogue, derived from the Latin and Greek analogia, has always been used to describe structural and functional similarity. Extended to drugs, this definition implies that the analogue of an existing drug molecule shares structural and pharmacological similarities with the original compound. Formally, this definition allows the establishment of three categories of drug analogues: analogues possessing chemical and pharmacological similarities (direct analogues); analogues possessing structural similarities only (structural analogues); and chemically different compounds displaying similar pharmacological properties (functional analogues).


Asunto(s)
Diseño de Fármacos , Preparaciones Farmacéuticas/química , Animales , Antidepresivos/química , Antidepresivos/farmacología , Celecoxib , Antagonistas Colinérgicos/química , Antagonistas Colinérgicos/farmacología , Diseño Asistido por Computadora , Inhibidores de la Ciclooxigenasa/química , Inhibidores de la Ciclooxigenasa/farmacología , Ciproheptadina/análogos & derivados , Ciproheptadina/química , Ciproheptadina/farmacología , Evaluación Preclínica de Medicamentos , Antagonistas del GABA/química , Antagonistas del GABA/farmacología , Humanos , Estructura Molecular , Pirazoles/química , Pirazoles/farmacología , Estereoisomerismo , Relación Estructura-Actividad , Sulfonamidas/química , Sulfonamidas/farmacología
15.
Biol Pharm Bull ; 28(12): 2197-200, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16327148

RESUMEN

The effect of ethanol extract obtained from Bulgaria inquinans on the scratching behavior and vascular permeability changes induced by compound 48/80, histamine and serotonin in ICR mice was studied. The extract dose-dependently inhibited scratching behavior induced by compound 48/80 and serotonin. A significant inhibition was observed at doses of 300 and 600 mg/kg when Bulgaria inquinans extract was administered orally. However, no inhibitory effect was observed on the histamine-induced scratching behavior by the extract, even at a dose of 600 mg/kg. In addition, it also inhibited the increase in the vascular permeability induced by compound 48/80 and serotonin at doses of 300 and 600 mg/kg; however, it failed to inhibit the increased vascular permeability induced by histamine, even at a dose of 600 mg/kg. Bulgaria inquinans extract showed a potent inhibitory effect on histamine release induced by compound 48/80. These results suggest that Bulgaria inquinans extract is effective in cutaneous pruritus and erythema, which were probably mediated by inhibiting the release of histamine from mast cells and antagonizing the effect on serotonin.


Asunto(s)
Ascomicetos/química , Mezclas Complejas/farmacología , Eritema/prevención & control , Prurito/prevención & control , Administración Oral , Animales , Ascomicetos/aislamiento & purificación , Conducta Animal/efectos de los fármacos , Permeabilidad Capilar/efectos de los fármacos , Mezclas Complejas/administración & dosificación , Mezclas Complejas/química , Ciproheptadina/farmacología , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Eritema/inducido químicamente , Eritema/tratamiento farmacológico , Femenino , Histamina/efectos adversos , Histamina/metabolismo , Cetotifen/farmacología , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/metabolismo , Ratones , Ratones Endogámicos ICR , Prurito/inducido químicamente , Prurito/tratamiento farmacológico , Ratas , Ratas Wistar , Serotonina , Suspensiones/administración & dosificación , p-Metoxi-N-metilfenetilamina
16.
Pharmacol Biochem Behav ; 78(4): 719-25, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15301927

RESUMEN

In the search for natural compounds useful against pruritus, alpha,beta-amyrins, the pentacyclic triterpenes isolated from the resin of popular medicinal plant Protium heptaphyllum were examined on scratching behavior induced by dextran T40 and compound 48/80 in mice. The animals were pretreated orally with alpha,beta-amyrins (50, 100 and 200 mg/kg) or cyproheptadine (10 mg/kg), an antagonist of histamine and serotonin receptors and 2 h later, they were given subcutaneous injections of dextran T40 (75 mg/kg) or compound 48/80 (3 mg/kg) into the rostral back, and scratching was quantified for 20 min. The scratching behavior induced by dextran T40 and compound 48/80 was significantly inhibited in mice pretreated with alpha,beta-amyrins (100 and 200 mg/kg) or cyproheptadine (10 mg/kg), In addition, the compound 48/80-elicited degranulation of rat peritoneal mast cells (ex vivo) was also markedly reduced in animals pretreated with alpha,beta-amyrins (100 mg/kg) or ketotifen (1 mg/kg), a known mast cell stabilizer. In the open-field test, alpha,beta-amyrins (100 and 200 mg/kg)-pretreated mice showed no impairment of spontaneous locomotion, suggesting that these triterpenoids possess no sedative activity that could account for suppression of scratching behavior. These results clearly indicate the antipruritic effect of alpha,beta-amyrins and suggest that this effect may be related to a stabilizing action on mast cell membrane.


Asunto(s)
Conducta Animal/efectos de los fármacos , Ácido Oleanólico/análogos & derivados , Ácido Oleanólico/farmacología , Prurito/tratamiento farmacológico , Prurito/psicología , Analgésicos Opioides/farmacología , Animales , Degranulación de la Célula/efectos de los fármacos , Ciproheptadina/farmacología , Dextranos , Endorfinas/fisiología , Femenino , Antagonistas de los Receptores Histamínicos H1/farmacología , Cetotifen/farmacología , Mastocitos/efectos de los fármacos , Mastocitos/ultraestructura , Ratones , Morfina/farmacología , Actividad Motora/efectos de los fármacos , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Cavidad Peritoneal/citología , Prurito/inducido químicamente , Receptores Opioides mu/efectos de los fármacos , p-Metoxi-N-metilfenetilamina
17.
Planta Med ; 68(4): 311-5, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11988853

RESUMEN

From the galls of Pistacia terebinthus we obtained an extract that proved to be effective against chronic and acute inflammation. Now we report on the isolation and identification of three triterpenes: two tirucallane-type lanostanoids and one oleanane, which we have identified as masticadienonic acid (1), masticadienolic acid (2), and morolic acid (3), respectively. All of them showed effectiveness on the mouse ear inflammation induced by repeated applications of 12-O-tetradecanoylphorbol 13-acetate and on the phospholipase A2-induced foot paw edema. The pharmacological activity of the compounds was ratified by a histological study of the ear samples. In addition, they inhibited leukotriene B4 production in rat polymorphonuclear leukocytes stimulated with calcium ionophore A 23187.


Asunto(s)
Antiinflamatorios/farmacología , Pistacia , Triterpenos/farmacología , Animales , Calcimicina/farmacología , Ciproheptadina/farmacología , Dexametasona/farmacología , Relación Dosis-Respuesta a Droga , Miembro Posterior/efectos de los fármacos , Inflamación/inducido químicamente , Inflamación/prevención & control , Ionóforos/farmacología , Leucotrieno B4/antagonistas & inhibidores , Leucotrieno B4/metabolismo , Espectroscopía de Resonancia Magnética , Ratones , Neutrófilos/efectos de los fármacos , Fosfolipasas A/farmacología , Fosfolipasas A2 , Extractos Vegetales/farmacología , Acetato de Tetradecanoilforbol/farmacología , Triterpenos/química , Triterpenos/aislamiento & purificación
18.
Cent Afr J Med ; 46(1): 9-13, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14674200

RESUMEN

OBJECTIVE: To investigate the effects of Heteromorpha trifoliata on rat uterine and skeletal muscle. DESIGN: Laboratory based study using experimental animals. Investigating the effects of the plant extract and agonists on isolated muscle preparations. SETTING: Department of Physiology, University of Zimbabwe. SUBJECTS: 28 Sprague-Dawley rats. MAIN OUTCOME MEASURES: Amplitude of contraction of uterine smooth muscle and skeletal muscle. RESULTS: Experiments were performed on the isolated rat uterus preparation in which strips of myometrium were placed in tissue baths filled with Kreb's solution. The aqueous extract of the root bark of Heteromorpha trifoliata ("dombwe") contracted the rat uterus. The contractions were not antagonised by atropine but were blocked by both cyproheptadine and verapamil. In addition, "dombwe" induced a contracture of the rat diaphragm muscle in the presence of alcuronium. CONCLUSIONS: The contractile effects on the uterus appear to involve stimulation of 5-HT2 receptors leading to an increase in calcium influx into the smooth muscle cell. Promotion of calcium influx could also explain the effects observed on the skeletal muscle preparation since the contracture induced by "dombwe" occurred in the presence of the nicotinic antagonist, alcuronium. In view of the effects of "dombwe" on other smooth muscle preparations (from previous work) it appears that the pharmacological profile of the crude aqueous extract of the root bark of Heteromorpha trifoliata is complex and suggestive of the presence of more than one active ingredient.


Asunto(s)
Apiaceae/fisiología , Medicinas Tradicionales Africanas , Contracción Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Miometrio/efectos de los fármacos , Fitoterapia/métodos , Extractos Vegetales/farmacología , Contracción Uterina/efectos de los fármacos , Alcuronio/farmacología , Animales , Atropina/farmacología , Bloqueadores de los Canales de Calcio/farmacología , Ciproheptadina/farmacología , Evaluación Preclínica de Medicamentos , Femenino , Técnicas In Vitro , Masculino , Antagonistas Muscarínicos/farmacología , Antagonistas Nicotínicos/farmacología , Corteza de la Planta/fisiología , Extractos Vegetales/agonistas , Extractos Vegetales/antagonistas & inhibidores , Ratas , Ratas Sprague-Dawley , Receptores de Serotonina 5-HT2/efectos de los fármacos , Antagonistas de la Serotonina/farmacología , Verapamilo/farmacología , Zimbabwe
19.
J Neurochem ; 72(4): 1372-83, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10098838

RESUMEN

Serotonin [5-hydroxytryptamine (5-HT)] modulates feeding activity, egg-laying, and mating behavior in the free-living nematode, Caenorhabditis elegans. We have cloned a novel receptor cDNA from C. elegans (5-HT2Ce) that has high sequence homology with 5-HT2 receptors from other species. When transiently expressed in COS-7 cells, 5-HT2Ce exhibited 5-HT binding activity and activated Ca2+-mediated signaling in a manner analogous to other 5-HT2 receptors. However, 5-HT2Ce displayed unusual pharmacological properties, which resembled both 5-HT2 and 5-HT1-like receptors but did not correlate well with any of the known 5-HT2 subtypes. Two splice variants of 5-HT2Ce that differ by 48 N-terminal amino acids were identified. The two isoforms were found to have virtually identical binding and signaling properties but differed in their levels of mRNA expression, with the longer variant being four times more abundant than the shorter species in all developmental stages tested. Taken together, the results describe two variants of a novel C. elegans 5-HT receptor, which has some of the properties of the 5-HT2 family but whose pharmacological profile does not conform to any known class of receptor.


Asunto(s)
Caenorhabditis elegans/genética , Empalme del ARN/fisiología , Receptores de Serotonina/genética , Aequorina/análisis , Animales , Secuencia de Bases , Unión Competitiva/efectos de los fármacos , Células COS , Calcio/metabolismo , Señalización del Calcio/efectos de los fármacos , Señalización del Calcio/fisiología , Clonación Molecular , Ciproheptadina/farmacología , ADN Complementario/aislamiento & purificación , Depuradores de Radicales Libres/farmacología , Expresión Génica/fisiología , Radioisótopos de Yodo , Ligandos , Lisurida/farmacología , Metiotepina/farmacología , Datos de Secuencia Molecular , Sistema Nervioso/química , ARN Mensajero/análisis , Receptor de Serotonina 5-HT2C , Receptores de Serotonina/metabolismo , Homología de Secuencia de Aminoácido , Serotonina/farmacología , Antagonistas de la Serotonina/farmacología , Agonistas de Receptores de Serotonina/farmacología , Transfección
20.
Photochem Photobiol ; 65(5): 895-901, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9155263

RESUMEN

The phthalocyanines are promising second-generation photosensitizers that are being evaluated for the photodynamic therapy (PDT) of malignant tumors. In vivo studies with the silicon phthalocyanine Pc 4 have shown that it is highly effective at causing regression of RIF-1 tumors in C3H/HeN mice in PDT protocols. Because cutaneous photosensitivity is the major complication of photosensitizers used for PDT, experiments were performed to evaluate the effect of inhibitors of the inflammatory response (cyproheptadine, dexamethasone, pentoxifylline, and tumor necrosis factor alpha [TNF-alpha] antibodies) on Pc 4-induced cutaneous photosensitivity and tumor regression. The C3H/HeN mice were injected with either Pc 4 or Photofrin and were exposed to 86 J/cm2 of filtered radiation emitted from a solar simulator. Animals were irradiated at 1, 3, 7, 10, 14 and 28 days postinjection. Cutaneous photosensitivity was assessed using the murine ear-swelling response. Cyproheptadine, dexamethasone, pentoxifylline and TNF-alpha antibodies were administered prior to illumination to assess their ability to block Pc 4-induced cutaneous photosensitivity and to evaluate whether such treatment adversely influenced Pc 4 PDT-induced tumor regression. Compared to Photofrin, Pc 4 produced cutaneous photosensitivity that was transient, resolving within 24 h, and that could be elicited for only 10 days after administration. In contrast, Photofrin caused photosensitivity that required 4 days to resolve and could be elicited for at least 1 month after it was administered. The Pc 4-induced cutaneous photosensitivity could be blocked by corticosteroids and an inhibitor of vasoactive amines (cyproheptadine). The TNF-alpha gene transcription was found to increase in keratinocytes following treatment with Pc 4 and light. The anti-TNF-alpha antibodies and pentoxifylline, an inhibitor of cytokine transcription, also prevented cutaneous photosensitivity, implicating TNF-alpha in the pathogenesis of Pc 4-induced cutaneous photosensitivity. None of these agents had any effect on Pc 4 PDT-induced tumor regression. Cyproheptadine, dexamethasone, pentoxifylline and TNF-alpha antibodies may be valuable pharmacologic agents in the management of cutaneous photosensitivity associated with PDT without altering the efficacy of this new therapeutic modality. The findings suggest that it should be possible to devise PDT protocols that block cutaneous photosensitivity without impairing the anti-tumor response to the agents.


Asunto(s)
Antineoplásicos/uso terapéutico , Indoles/uso terapéutico , Neoplasias Experimentales/terapia , Compuestos de Organosilicio/uso terapéutico , Fármacos Fotosensibilizantes/uso terapéutico , Fototerapia , Tolerancia a Radiación/efectos de los fármacos , Silanos , Piel/efectos de los fármacos , Animales , Antiinflamatorios/farmacología , Antipruriginosos/farmacología , Ciproheptadina/farmacología , Dexametasona/farmacología , Derivado de la Hematoporfirina/efectos adversos , Rayos Láser , Ratones , Ratones Endogámicos C3H , Pentoxifilina/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Fototerapia/efectos adversos , Piel/efectos de la radiación , Factor de Necrosis Tumoral alfa/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA